1. Mareev, V.Yu., Ageev, F.T., Arutyunov, A.G., Koroteev, A.V., and Revishvili, F.V., National Recommendations WNOK and OSSN about the Diagnostics and Treatment of CHF) (the Third Revision), Serdech. Nedostat., 2010, vol. 11, no. 1, pp. 3–62.
2. Arutyunov, G.P. and Ageev, F.T., The Hypolipidemic Therapy in Patients with CHF. Whom? When? By What?, Serdech. Nedostat., 2003, vol. 4, no.4, pp. 206–212.
3. Velavan, P., Huan Loh, P., Clark, A., and Cleland, J.G., The Cholesterol Paradox in Heart Failure, Congest. Heart Fail., 2007, vol. 13, no. 6, pp. 336–341.
4. Horwich, T., Low-Density Lipoprotein in the Setting of Congestive Heart Failure: Is Lower Really Better?, Curr. Atheroscler. Rep., 2009, vol. 11, no. 5, pp. 343–349.
5. Rauchhaus, M., Clark, A.L., Doehner, W., Davos, C., Bolger, A., Sharma, R., Coats, A.J.S., and Anker, S.D., The Relationship between Cholesterol and Survival in Patients with Chronic Heart Failure, J. Am. Coll. Cardiol., 2003, vol. 42, pp. 1933–1943.